New Generation Bone Cement with Sustainable Antibiotic Delivery - Shen, Shoucang;Ng, Wai Kiong;Tan, Reginald Beng Hee
23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

The nano formulation is expected to deliver the next generation bone cement with tailor-designed antibiotics release profiles and prolonged antibacterial activity. The key commercial advantages to potential bone cement manufacturers and end users are sustained antibiotics release, reduction in standard antibiotics dosage, minimised use of intravenous doses and creating new opportunities to use other benefit ingredient for local targeted delivery. Once commercialized, the socio-economic impact and savings in medical resources and costs are expected to be significant as the risk of post-operative infections can be reduced.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The nano formulation is expected to deliver the next generation bone cement with tailor-designed antibiotics release profiles and prolonged antibacterial activity. The key commercial advantages to potential bone cement manufacturers and end users are sustained antibiotics release, reduction in standard antibiotics dosage, minimised use of intravenous doses and creating new opportunities to use other benefit ingredient for local targeted delivery. Once commercialized, the socio-economic impact and savings in medical resources and costs are expected to be significant as the risk of post-operative infections can be reduced.
Autorenporträt
Dr Shen obtained PhD degree in 2001 and joined Institute of Chemical and Engineering Sciences at 2005. Dr Shen focused on drug formulation using nanostructure materials. To date, Dr Shen has published more than 60 academic journal papers and 5 book chapters. 2 US patents and 2 Singapore patents were granted, 1 PCT patent has been filed.